2 búsqueda de la palabra clave 'O6-methylguanine-DNA methyltransferase (MGMT)'

Treatment of aggressive pituitary adenomas and carcinomas – an overview / Luis Vicente Syro Moreno  

Público ISBD Título : Treatment of aggressive pituitary adenomas and carcinomas – an overview Tipo de documento : documento electrónico Autores : Luis Vicente Syro Moreno, Fecha de publicación : 2012 Títulos uniformes : European Neurological Review Idioma : Inglés (eng) Palabras clave : Pituitary adenoma  pituitary carcinoma  O6-methylguanine-DNA methyltransferase (MGMT)  temozolomide  everolimus  bevacizumab Resumen : Most pituitary tumours are non-invasive, benign adenomas that remain confined to the sella turcica. Some of them recur, have a rapid growth rate, and invade surrounding tissues. These adenomas, considered aggressive pituitary tumours, are difficult to manage and present problems due to incomplete resection. A pituitary carcinoma is diagnosed when craniospinal and/or systemic metastases are documented. Treatment options for pituitary adenomas are surgery, radiation and drugs. Recent publications report the efficacy of temozolomide in the treatment of aggressive pituitary adenomas and carcinomas. Indications for, results with, and side effects of temozolomide therapy in aggressive pituitary tumours and pituitary carcinomas are reviewed here. Alternative treatment options for resistant or recurrent pituitary tumours are also discussed. Mención de responsabilidad : Luis V Syro, Leon D Ortiz, Fabio Rotondo, Humberto Uribe, Luis C Penagos, Eva Horvath, Kalman Kovacs Referencia : European Neurological Review. 2012;7(3):178–80. DOI (Digital Object Identifier) : 10.17925/ENR.2012.07.03.178 En línea : https://touchneurology.com/treatment-of-aggressive-pituitary-adenomas-and-carcin [...] Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=3630 Treatment of aggressive pituitary adenomas and carcinomas – an overview [documento electrónico] / Luis Vicente Syro Moreno,  . - 2012. Obra : European Neurological Review Idioma : Inglés (eng) Palabras clave : Pituitary adenoma  pituitary carcinoma  O6-methylguanine-DNA methyltransferase (MGMT)  temozolomide  everolimus  bevacizumab Resumen : Most pituitary tumours are non-invasive, benign adenomas that remain confined to the sella turcica. Some of them recur, have a rapid growth rate, and invade surrounding tissues. These adenomas, considered aggressive pituitary tumours, are difficult to manage and present problems due to incomplete resection. A pituitary carcinoma is diagnosed when craniospinal and/or systemic metastases are documented. Treatment options for pituitary adenomas are surgery, radiation and drugs. Recent publications report the efficacy of temozolomide in the treatment of aggressive pituitary adenomas and carcinomas. Indications for, results with, and side effects of temozolomide therapy in aggressive pituitary tumours and pituitary carcinomas are reviewed here. Alternative treatment options for resistant or recurrent pituitary tumours are also discussed. Mención de responsabilidad : Luis V Syro, Leon D Ortiz, Fabio Rotondo, Humberto Uribe, Luis C Penagos, Eva Horvath, Kalman Kovacs Referencia : European Neurological Review. 2012;7(3):178–80. DOI (Digital Object Identifier) : 10.17925/ENR.2012.07.03.178 En línea : https://touchneurology.com/treatment-of-aggressive-pituitary-adenomas-and-carcin [...] Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=3630

Reserva

Reservar este documento

Ejemplares(1)

Código de barras	Número de Ubicación	Tipo de medio	Ubicación	Sección	Estado
DD000200	AC-2012-040	Archivo digital	Producción Científica	Artículos científicos	Disponible

Treatment of aggressive pituitary adenomas and carcinomas-An overview / Luis Vicente Syro Moreno  

Público ISBD Título : Treatment of aggressive pituitary adenomas and carcinomas-An overview Tipo de documento : documento electrónico Autores : Luis Vicente Syro Moreno, Fecha de publicación : 2012 Títulos uniformes : US Endocrinology Idioma : Inglés (eng) Palabras clave : Pituitary adenoma  pituitary carcinoma  O6-methylguanine-DNA methyltransferase (MGMT)  temozolomide  everolimus  bevacizumab Resumen : Most pituitary tumors are non-invasive, benign adenomas that remain confined to the sella turcica. Some of them recur, have a rapid growth rate, and invade surrounding tissues. These adenomas, considered aggressive pituitary tumors, are difficult to manage and present problems due to incomplete resection. A pituitary carcinoma is diagnosed when craniospinal and/or systemic metastases are documented. Treatment options for pituitary adenomas are surgery, radiation, and drugs. Recent publications report the efficacy of temozolomide in the treatment of aggressive pituitary adenomas and carcinomas. Indications for, results with, and side effects of temozolomide therapy in aggressive pituitary tumors and pituitary carcinomas are reviewed here. Alternative treatment options for resistant or recurrent pituitary tumors are also discussed. Mención de responsabilidad : Luis V Syro, Leon D Ortiz, Fabio Rotondo, Humberto Uribe, Luis C Penagos, Eva Horvath, Kalman Kovacs DOI (Digital Object Identifier) : 10.17925/USE.2012.08.01.50 En línea : https://www.touchendocrinology.com/treatment-of-aggressive-pituitary-adenomas-an [...] Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4505 Treatment of aggressive pituitary adenomas and carcinomas-An overview [documento electrónico] / Luis Vicente Syro Moreno,  . - 2012. Obra : US Endocrinology Idioma : Inglés (eng) Palabras clave : Pituitary adenoma  pituitary carcinoma  O6-methylguanine-DNA methyltransferase (MGMT)  temozolomide  everolimus  bevacizumab Resumen : Most pituitary tumors are non-invasive, benign adenomas that remain confined to the sella turcica. Some of them recur, have a rapid growth rate, and invade surrounding tissues. These adenomas, considered aggressive pituitary tumors, are difficult to manage and present problems due to incomplete resection. A pituitary carcinoma is diagnosed when craniospinal and/or systemic metastases are documented. Treatment options for pituitary adenomas are surgery, radiation, and drugs. Recent publications report the efficacy of temozolomide in the treatment of aggressive pituitary adenomas and carcinomas. Indications for, results with, and side effects of temozolomide therapy in aggressive pituitary tumors and pituitary carcinomas are reviewed here. Alternative treatment options for resistant or recurrent pituitary tumors are also discussed. Mención de responsabilidad : Luis V Syro, Leon D Ortiz, Fabio Rotondo, Humberto Uribe, Luis C Penagos, Eva Horvath, Kalman Kovacs DOI (Digital Object Identifier) : 10.17925/USE.2012.08.01.50 En línea : https://www.touchendocrinology.com/treatment-of-aggressive-pituitary-adenomas-an [...] Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4505

Reserva

Reservar este documento

Ejemplares(1)

Código de barras	Número de Ubicación	Tipo de medio	Ubicación	Sección	Estado
DD001004	AC-2012-093	Archivo digital	Producción Científica	Artículos científicos	Disponible